Concepedia

Erik Skjelbo

ES

11

Publications

1.3K

Citations

11

H-Index

1991

Active since

Affiliations

Odense University Hospital(Current)

University of Southern Denmark

University College Lillebaelt

Amref Health Africa

Erik Skjelbo is an author at Odense University Hospital specializing in medicine, drug discovery, and pharmacotherapy.

Top concepts

Publications per year

1991–2002

11

Publications

11

Fluvoxamine is a potent inhibitor of cytochrome P4501A2

Kim Brøsen, Erik Skjelbo, Birgitte Buur Rasmussen et al. · Biochemical Pharmacology · 1993 · 371 citations

, , +7

The relationship between paroxetine and the sparteine oxidation polymorphism

Søren H. Sindrup, Kim Brøsen, Lars F. Gram et al. · Clinical Pharmacology & Therapeutics · 1992 · 207 citations

, , +14

Inhibitors of imipramine metabolism by human liver microsomes.

Erik Skjelbo · British Journal of Clinical Pharmacology · 1992 · 163 citations · Full text

The activation of the biguanide antimalarial proguanil co‐segregates with the mephenytoin oxidation polymorphism‐a panel study.

Erik Skjelbo, LF Gram, AM Breckenridge · British Journal of Clinical Pharmacology · 1991 · 162 citations

The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine

Erik Skjelbo, Kim Brøsen, Jesper Hallas et al. · Clinical Pharmacology & Therapeutics · 1991 · 141 citations

Rows per page

1–5 of 11